Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- New York, New York
- Most recent report
- 8-K, filed Aug 11, 2026
- Incorporated
- Delaware
- Filings on record
- 1,001+ filings
- On EDGAR
- CIK 1390478
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer Smaller reporting company
Financials 8 of 70
News 8 of 278
Prospectuses and Registrations 8 of 112
- S-8 Registration statement for an employee plan Jun 16, 2026
- S-3ASR Automatic shelf registration Mar 20, 2026
- 424B5 Prospectus supplement for an offering Oct 27, 2025
- S-3 Shelf registration statement Oct 10, 2025
- S-8 Registration statement for an employee plan Aug 12, 2025
- 424B5 Prospectus supplement for an offering Jan 29, 2025
- 424B5 Prospectus supplement for an offering Aug 1, 2024
- S-3/A Shelf registration statement, amended Apr 29, 2024
Proxies 8 of 55
- DEFA14A Extra proxy material Apr 23, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 23, 2026
- DEFA14A Extra proxy material Jun 10, 2025
- DEFA14A Extra proxy material Apr 23, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 23, 2025
- DEFA14A Extra proxy material Apr 29, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 29, 2024
- DEFA14A Extra proxy material Apr 28, 2023
Ownership 8 of 347
- SCHEDULE 13G Large holder reported a passive stake Aug 7, 2026
- SCHEDULE 13G Large holder reported a passive stake Jul 31, 2026
- 4 Insider reported a trade Jun 18, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Apr 24, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Mar 27, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Feb 17, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Jan 30, 2026
- 4 Insider reported a trade Jan 9, 2026
Other 8 of 139
- ARS Annual report sent to shareholders Apr 23, 2026
- EFFECT Notice that a registration became effective Nov 25, 2025
- CORRESP Reply to SEC staff Nov 21, 2025
- ARS Annual report sent to shareholders Apr 23, 2025
- EFFECT Notice that a registration became effective May 1, 2024
- EFFECT Notice that a registration became effective May 1, 2024
- ARS Annual report sent to shareholders Apr 30, 2024
- CORRESP Reply to SEC staff Apr 29, 2024
Everything here comes from SELLAS Life Sciences Group, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.